Maximising Radiopharmaceutical Development Through In-silico Modelling
Time: 3:15 pm
day: P&T Track PM
Details:
- Outlining proprietary in-silico model
- Identifying optimal targeting approaches to be implemented
- Assessing isotope and chelator selection
